Immuron IMRN
NASDAQ IMRN
$1.18 -0.01 (-0.87%)
As of: Sep 30, 2026 · 9:44 AM EDT

Immuron (IMRN) Convertible Debt (2017)

Updated

Immuron's Convertible Debt was $173,272 in FY2017 (year ended Dec 31, 2017).

Analysis

Immuron (IMRN) Convertible Debt (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Immuron 9.36 Mn -7.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 173,802.71
Jun 30, 2017 169,773.53
API Access

Immuron Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=IMRN&period=max&api_key=YOUR_API_KEY